Annals of Internal Medicine, tip sheet, November 18, 2003

November 17, 2003

49% of American Physicians Support National Health Insurance, Study Finds

A substantial proportion of U.S. doctors support national health insurance, a new study finds (Article, p. 795). Among 1,650 primary care physicians, surgeons, and specialists responding to a survey, 49 percent supported governmental legislation to establish universal national health insurance, and 40 percent opposed it. Nearly one quarter (26 percent) supported a program in which the government would pay for all health care. Support for national health insurance varied by specialty, location and practice setting. Doctors were most likely to back national health insurance if they practiced in inner cities or in nonprivate settings and if at least 20 percent of their patients were on Medicaid. An editorial says "physicians may disagree on how best to cover the uninsured," but that "the status quo should be everyone's last choice" (Editorial, p. 858).

Mammography Is Cost-Effective Beyond Age 65, Study Finds

A cost-effectiveness analysis of data in 10 published studies finds that mammography screening for breast cancer every two years reduces death at reasonable cost for 65- to 80-year-old women who have no serious life-threatening health conditions (Review, p. 835). The strength of the conclusions is limited somewhat by the scarcity of high quality research on breast cancer screening and treatment in this age group, but the authors say the results should provide information to guide clinical recommendations, clinical standards of care, and policy on optimal use of breast cancer screening for older women.

Intensive HIV Therapy Can Be Started Later Than Thought, With Caveats

A new observational study of 1,422 HIV-infected adults found that patients with CD4 counts of 200 cells/uL (cells per microliter) or above who complied with the drug regimens of highly active antiretroviral therapy (HAART) had low death rates (Article, p. 810). Among patients who adhered to treatment, survival was similar regardless of the CD4 cell counts at initiation of therapy. Patients with CD4 cell counts of 200 and above who did not refill their drug prescriptions regularly and who presumably did not comply with complicated HAART regimens had higher death rates. The authors conclude that delaying HAART until the CD4 cell count falls to 200 does not increase the mortality rate if the patients comply with the drug regimens. Adherence to the medication regimens is the critical determinant of survival, not the CD4 cell count when HAART is begun, they say.
-end-
Annals of Internal Medicine is published by the American College of Physicians, an organization of more than 115,000 internal medicine physicians and medical students. These highlights are not intended to substitute for articles as sources of information. For an embargoed fax of an article, call 1-800-523-1546, ext. 2656, or 215-351-2656.

American College of Physicians

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.